Targeted delivery to the skin for local action (e.g., inflammation, infection, or barrier repair). Expertise in optimizing formulation penetration, retention, and patient experience for creams, gels, ointments, sprays, and foams. 

Fast-acting, non-invasive delivery directly to the lungs through nasal or oral routes, enabling rapid onset, reduced systemic side effects, and effective treatment of both respiratory and systemic conditions. Includes spray formulation design, viscosity tuning, droplet size analysis, and mucosal retention testing.

Sterile or preservative-containing formulations for ocular delivery. Expertise in particle suspension stability, viscosity control, and packaging compatibility for drops, gels, and sprays. 

Formulations for direct absorption through sensitive and highly vascularized mucosa. Includes compatibility testing, retention optimization, and patient-centric dose forms like gels, foams, and suppositories.

Specialized formulations for treating outer and middle ear conditions. Focus on retention, comfort, and antimicrobial performance in dose forms like drops, foams, and gels. Custom models support precise efficacy and safety testing.

Niche delivery routes for difficult-to-penetrate tissues. MedPharm offers proprietary nail permeation models and specialized testing platforms for scalp/follicular delivery and keratinized tissue applications. 

Creating optimized topical and transdermal formulations to enhance drug delivery and patient outcomes.

Advancing Formulations for Localized and Systemic GI Therapies At MedPharm, we specialize in the development of innovative drug products targeting the gastrointestinal (GI) tract, with expertise spanning topical GI treatments to systemic therapies delivered via mucosal absorption. Whether you are formulating for localized conditions or systemic bioavailability through oral mucosal, esophageal, or rectal delivery, our team applies a science-driven approach to maximize therapeutic outcomes.